COMMUNIQUÉS West-GlobeNewswire

Delcath Announces Third Quarter Fiscal 2018 Financial Results
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Delcath Systems, Inc. (OTCQB: DCTH), an interventional oncology company focused on the treatment of primary and metastatic liver cancers, announces financial results for the [...]
Altimmune Announces Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
GAITHERSBURG, Md., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage immunotherapeutics company, today announced financial results for the three and nine months ended September 30, 2018. [...]
Zomedica Pharmaceuticals Corp. Announces Third Quarter 2018 Financial Results
13/11/2018
ANN ARBOR, Mich., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Zomedica Pharmaceuticals Corp. (NYSE American: ZOM) (TSX-V: ZOM) (“Zomedica” or “Company”), a veterinary diagnostic and pharmaceutical company, today reported [...]
National Brain Tumor Society Supported Work Features in 19 Presentations at 2018 Society for Neuro-Oncology Annual Meeting
13/11/2018
Boston, MA, Nov. 13, 2018 (GLOBE NEWSWIRE) -- National Brain Tumor Society (NBTS), the largest nonprofit dedicated to the brain tumor community in the United States, today announced that its funded research, programs, [...]
Molecular Templates, Inc. Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
AUSTIN, Texas, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Molecular Templates, Inc. (Nasdaq: MTEM, “Molecular” or “Molecular Templates”), a clinical-stage oncology company focused on the discovery and development of the company’ [...]
Adverum to Present at 30th Annual Piper Jaffray Healthcare Conference
13/11/2018
MENLO PARK, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Adverum Biotechnologies, Inc. (Nasdaq: ADVM), a clinical-stage gene therapy company targeting unmet medical needs in ophthalmology and rare diseases, today announced [...]
Alcon files initial Form 20-F registration statement with SEC for proposed spinoff; plans investor days in New York and London
13/11/2018
Basel, November 13, 2018 - Novartis today announced that Alcon has filed an initial Form 20-F registration statement with the US Securities and Exchange Commission (SEC) in relation to the previously-announced intention [...]
Mustang Bio Reports Third Quarter 2018 Financial Results and Recent Corporate Highlights
13/11/2018
NEW YORK, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a company focused on the development of novel immunotherapies based on proprietary chimeric antigen receptor engineered T cell (“ [...]
Homology Medicines Reports Third Quarter 2018 Financial Results
13/11/2018
On Track to Begin and Report Initial Clinical Data from PKU Gene Therapy Trial and to Start IND-Enabling Studies in PKU Gene Editing and MLD Gene Therapy Programs Next Year BEDFORD, Mass., Nov. 13, 2018 (GLOBE NEWSWIRE [...]
Teligent, Inc. Announces Third Quarter 2018 Results
13/11/2018
BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT) (the "Company"), a New Jersey-based specialty generic pharmaceutical company, today announced its financial results for the third quarter [...]
Teligent, Inc. Announces $120 Million Financing Commitment From Ares
13/11/2018
BUENA, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Teligent, Inc. (NASDAQ: TLGT), (“Teligent” or the “Company”) announced today that the Company secured a financing commitment from funds managed by Ares Management, L.P. (“ [...]
Resonant Inc. Reports Third Quarter 2018 Financial Results and Provides Business Update
13/11/2018
GOLETA, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Resonant Inc. (NASDAQ: RESN), a leader in transforming the way radio frequency, or RF, front-ends are being designed and delivered for mobile handset and wireless [...]
electroCore, Inc. Announces Third Quarter Financial Results
13/11/2018
BASKING RIDGE, N.J., Nov. 13, 2018 (GLOBE NEWSWIRE) -- electroCore, Inc. (“electroCore”) (Nasdaq: ECOR), a commercial-stage bioelectronic medicine company, today reported financial results for the three months and nine [...]
Merit Medical Closes Cianna Medical, Inc. Deal
13/11/2018
SOUTH JORDAN, Utah, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a leading manufacturer and marketer of proprietary disposable devices used in interventional, diagnostic and therapeutic [...]
Evoke Pharma Reports Third Quarter 2018 Results
13/11/2018
April 1, 2019 PDUFA date for Gimoti™ NDA Cash runway extended through June 2019 SOLANA BEACH, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- Evoke Pharma, Inc. (NASDAQ: EVOK), a specialty pharmaceutical company focused on [...]
ImmuCell Announces Financial Results for Third Quarter of 2018
13/11/2018
PORTLAND, Maine, Nov. 13, 2018 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company that develops, manufactures and markets scientifically-proven and [...]
Marrone Bio Innovations, Inc. Reports Third Quarter 2018 Financial Results
13/11/2018
Year-Over-Year Revenues Increase 29% to Third Quarter Record of $5.4 Million; Gross Margins Expand to Record 48.3%; Operating Expenses Decrease by 19% to $6.8 Million DAVIS, Calif., Nov. 13, 2018 (GLOBE NEWSWIRE) -- [...]
Crinetics Pharmaceuticals Reports Third Quarter 2018 Financial Results and Provides Corporate Update
13/11/2018
SAN DIEGO, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development and commercialization of novel therapeutics for [...]
Sol-Gel Technologies Reports Third Quarter 2018 Financial Results
13/11/2018
NESS ZIONA, Israel, Nov. 13, 2018 (GLOBE NEWSWIRE) -- Sol-Gel Technologies Ltd. (NASDAQ: SLGL) (“Sol-Gel” or the “Company”), a clinical-stage dermatology company focused on identifying, developing and commercializing [...]

Pages